Related Experiment Video
Updated: Sep 13, 2025

06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.0K
Carbohydrate-Responsive Element-Binding Protein-Associated Metabolic Changes in Chemically Induced
Maren Engeler1, Majedul Karim1, Marcel Gischke1
1Institute for Pathology, University Medicine Greifswald, 17475 Greifswald, Germany.
International Journal of Molecular Sciences
|July 29, 2025
Summary
The Carbohydrate-Responsive Element-Binding Protein (ChREBP) plays a dual role in liver cancer. Its specific isoform, ChREBPα, promotes tumor growth, while ChREBPβ may suppress it.
Area of Science:
- Metabolic regulation
- Hepatocarcinogenesis research
- Transcription factor function
Background:
- Carbohydrate-Responsive Element-Binding Protein (ChREBP) is a key regulator of carbohydrate and lipid metabolism.
- Understanding ChREBP's role in liver cancer is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the cell-type-specific functions of ChREBP and its isoforms (ChREBPα and ChREBPβ) in hepatocarcinogenesis.
- To elucidate the distinct roles of ChREBPα and ChREBPβ in liver tumor initiation and progression.
Main Methods:
- Utilized a diethylnitrosamine (DEN)-induced mouse model for hepatocarcinogenesis.
- Employed systemic ChREBP-knockout (KO) and hepatocyte-specific ChREBP-KO (L-KO) mice.
- Analyzed tumors using histology, morphometry, proliferation assays, immunohistochemistry, Western blot, and qPCR.
Main Results:
- Hepatocyte-specific ChREBPα loss (L-KO) significantly reduced tumor progression and hepatocyte proliferation.
- Systemic ChREBP knockout (KO) decreased tumor initiation but had a minor effect on progression.
- KO tumors showed downregulated AKT/mTOR signaling, glycolysis, and lipogenesis compared to wildtype (WT) tumors.
Conclusions:
- ChREBPα has an oncogenic role in liver cancer, particularly when specifically lost in hepatocytes.
- ChREBPβ may possess tumor-suppressive functions, as indicated by systemic knockout results.
- Targeting ChREBPα could be a potential therapeutic strategy for hepatocarcinogenesis.
Keywords:
ChREBPPI3K/AKT/mTORcancer metabolismchemically induced hepatocarcinogenesisdiethylnitrosaminehepatocellular carcinomaMore Related Videos
Related Concept Videos
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Cell Specific Gene Expression
13.9K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.9K
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
